Peptide Decoding
New?New to peptides?Start here →
Decoding

Palmitoyl Tripeptide-8_Dosage, benefits & legal status

Also known as Neutrazen

Published October 13, 2026

A skin-calming ingredient built from three residues of a natural anti-inflammatory hormone, backed mainly by supplier tests.

Calm sensitive skinCosmetic peptide (topical)Cosmetic
DoseSerum or cream, per product
FrequencyDaily
RouteOn the skin (cream or serum)
StatusCosmetic ingredient
CycledDaily use

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Palmitoyl Tripeptide-8?

Plain language first. The technical label stays, but it never stands alone.

Overview

It goes into creams for sensitive, reddened or irritated skin. In the supplier's cell tests it lowered the inflammatory signal IL-8, and in 8 to 13 volunteers it reduced redness and heat after a chemical irritant. Independent evidence is limited to one stinging study and one multi-ingredient product trial without a control group.

The technical version

Palmitoyl tripeptide-8 is His-D-Phe-Arg, the core of the hormone alpha-MSH, with a palmitic acid tail and an amide end. It switches on the MC1 melanocortin receptor, one of the ways skin cells damp inflammation. French CNRS researchers patented it in 2004; Lucas Meyer Cosmetics sells it as Neutrazen, and Clariant has owned Lucas Meyer since April 2024.

What it's used for

A cosmetic ingredient in soothing creams and serums for sensitive or reactive skin, after-sun and post-procedure care.

02

How does Palmitoyl Tripeptide-8 work?

What it does in the body, and where.

Palmitoyl tripeptide-8 mimics alpha-MSH, a fragment of the skin's own pro-opiomelanocortin hormone.

  1. 01
    The receptor
    His-Phe-Arg is the core of alpha-MSH. With the phenylalanine in mirror-image form, the patent reports stronger MC1 receptor signalling than alpha-MSH itself in melanoma cells (half-maximal at 2.3 against 8.1 nanomolar).
  2. 02
    Calming signals
    MC1 receptor activation damps inflammatory signalling. In the supplier's tests, UVB-stressed skin cells released about 32% less IL-8, and irritated fibroblasts about 64% less.
  3. 03
    Fat tail
    The palmitic acid tail is meant to help it into the outer skin; no penetration data have been published.
Pathway
THE PEPTIDE
Palmitoyl Tripeptide-8
ACTS ON
MC1 melanocortin receptors on skin cells
RESULT
Less IL-8 released by irritated skin cells (lab data)
RESULT
Less redness and swelling in skin samples exposed to substance P

A schematic of the compound's mechanism, not a diagnostic image.

03

What else is it used for?

Each group carries its own evidence level.

Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

Supplier tests

Supplement or cosmetic
  • Lab studySkin cells stressed with UVB or IL-1 released 32 to 64% less IL-8.
  • Lab studyIn 4 donated skin samples exposed to substance P, swelling fell about 60% and dilated vessels about 30%.
  • No data8 and 13 volunteers: less heat and redness after a detergent irritant; no p-values, and one result is given as an impossible '-112%'.

Independent studies

Early research
  • Human trialA 2016 study in sensitive-skin volunteers found a POMC-mimicking peptide reduced capsaicin stinging against vehicle.
  • Human observationAn uncontrolled 25-person study of a serum with five actives reduced post-rosacea redness; the peptide's share cannot be separated.
Often left out

Lucas Meyer Cosmetics is now part of Clariant, not IFF. GSRS lists a wrong synonym with alanine in place of arginine, and some vendors call it palmitoyl tetrapeptide-8; it is a tripeptide. The IL-8 results are from cells, not 'in vivo'. The supplier's '-112%' temperature reduction cannot be right as a percentage. 'Clinically proven' rests on two supplier tests of 8 and 13 people, one independent study and one uncontrolled multi-ingredient study. Claims that the Cosmetic Ingredient Review confirmed its safety have no source; its 2018 peptide report covered other peptides. 'Neutrazen' is a trade name for one supplier's blend, not a generic name for the peptide.

The published record

Research index

6

Papers and trials about Palmitoyl Tripeptide-8

2 papers tagged human · 2 not reviews or lab · 0 clinical trial publications

Furthest stage reached: No clinical trial on record

Compare this against the whole library →

In animals1
In the lab0
Reviews1
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

Palmitoyl Tripeptide-8 vial rendering
Compound field notes

At a glance

Four things to know about Palmitoyl Tripeptide-8

01

Evidence

Cosmetic

02

Category

Skin and cosmetic

03

Common vial

Varies

04

Half-life

Not applicable (topical)

04

How much, and do you cycle it?

The range, and whether you take breaks.

Serum or cream, per product, daily. Daily use Community practice

Applied daily like other cosmetic actives. The supplier's preventive test used it three times a day for 8 days.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not applicable (topical)No figure

Applied to the skin. No skin penetration or blood-level data have been published.

You can compare this against the whole library to see where it sits.

06

What does it cost?

Typical dose and cost, in plain numbers.

Palmitoyl Tripeptide-8 is not injected

It is taken on the skin (cream or serum). The supplier's volunteer tests used about 4 micromolar of the peptide, roughly 2.8 ppm (0.00028%) of the finished formula. Resellers cite 2 to 8 ppm; Lucas Meyer's recommended level for Neutrazen is not public. The patent covers 0.01 micromolar to 1 millimolar, preferring 0.1 to 10 micromolar. Applied as a cosmetic; there is no injected dose.

Cost per month
—
Cost per dose
—
Typical dose
0.2 mcg–0.8 mcg / formulationCommunity practice
07

How do you store it?

Before mixing, and after.

Room temperature, out of light. Cap it tight after each use.

Palmitoyl Tripeptide-8 ships as a cream, gel, or serum. Keep it at room temperature away from sun and heat unless the label says otherwise. Refrigerating an emulsion can split the texture. Watch for color, smell, or separation changes and stop using it if any appear.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Injecting it: it is sold and tested only as a skin-care ingredient
  • Known sensitivity to a product that contains it

Stop and get help

These are emergencies. Seek care.
  • Redness, burning, itching or a rash where it is applied

Common effects

Expected, and usually mild.
  • No irritation or sensitisation data have been published, and no Cosmetic Ingredient Review assessment was found
  • Whether it darkens skin is unresolved: it activates the pigment receptor in melanoma cells, and the supplier says it showed no tanning effect without showing the data

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Palmitoyl Tripeptide-8 approved?

And where the numbers on this page come from.

Not as a medicine. Palmitoyl Tripeptide-8 is sold without a prescription as a cosmetic ingredient, which is a different thing from being approved as a drug.

What has happened recently

A cosmetic ingredient, not a drug. Listed in the EU cosmetic ingredient database (CosIng) under the INCI name Palmitoyl Tripeptide-8 with a skin-conditioning function and no restrictions. No Cosmetic Ingredient Review or EU SCCS safety assessment was found. One US mist is registered on DailyMed as an over-the-counter drug listing it as the active ingredient; that is a self-submitted listing, not an FDA approval. Patented by the CNRS and the Institut Europeen de Biologie Cellulaire (priority 2004); launched as Neutrazen by Atrium Innovations in 2007, then sold through Unipex and Lucas Meyer Cosmetics, owned by IFF from 2015 and by Clariant since April 2024.

Guides for this compound

Sources

Beyond these, 6 records are indexed. Browse the records